These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10549655)

  • 1. Photopic temporal processing in retinitis pigmentosa.
    Felius J; Swanson WH
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2932-44. PubMed ID: 10549655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of retinitis pigmentosa using the multifocal electroretinogram.
    Chan HL; Brown B
    Ophthalmic Physiol Opt; 1998 Jul; 18(4):335-50. PubMed ID: 9829106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cone dystrophy with "supernormal" rod ERG: psychophysical testing shows comparable rod and cone temporal sensitivity losses with no gain in rod function.
    Stockman A; Henning GB; Michaelides M; Moore AT; Webster AR; Cammack J; Ripamonti C
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):832-40. PubMed ID: 24370833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of acetazolamide on visual function in retinitis pigmentosa.
    Greenstein VC; Holopigian K; Siderides E; Seiple W; Carr RE
    Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):269-73. PubMed ID: 8425835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychophysically determined full-field stimulus thresholds (FST) in retinitis pigmentosa: relationships with electroretinography and visual field outcomes.
    Messias K; Jägle H; Saran R; Ruppert AD; Siqueira R; Jorge R; Messias A
    Doc Ophthalmol; 2013 Oct; 127(2):123-9. PubMed ID: 23733195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fundus autofluorescence with photopic and scotopic fine-matrix mapping in patients with retinitis pigmentosa and normal visual acuity.
    Robson AG; Egan CA; Luong VA; Bird AC; Holder GE; Fitzke FW
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4119-25. PubMed ID: 15505064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
    Nagy D; Schönfisch B; Zrenner E; Jägle H
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full-field ERG, multifocal ERG and multifocal VEP in patients with retinitis pigmentosa and residual central visual fields.
    Gränse L; Ponjavic V; Andréasson S
    Acta Ophthalmol Scand; 2004 Dec; 82(6):701-6. PubMed ID: 15606467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast thresholds for letter identification in retinitis pigmentosa.
    Alexander KR; Derlacki DJ; Fishman GA
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1846-52. PubMed ID: 1582787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity.
    Robson AG; Saihan Z; Jenkins SA; Fitzke FW; Bird AC; Webster AR; Holder GE
    Br J Ophthalmol; 2006 Apr; 90(4):472-9. PubMed ID: 16547330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral retinitis pigmentosa.
    Bhattarai D; Paudel N; Adhikari P; Gnyawali S; Joshi SN
    Nepal J Ophthalmol; 2015; 7(1):56-9. PubMed ID: 26695607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fundus autofluorescence with photopic and scotopic fine matrix mapping in patients with retinitis pigmentosa: 4- to 8-year follow-up.
    Robson AG; Lenassi E; Saihan Z; Luong VA; Fitzke FW; Holder GE; Webster AR
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6187-95. PubMed ID: 22899761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slowing the degenerative process, long lasting effect of hyperbaric oxygen therapy in retinitis pigmentosa.
    Vingolo EM; Rocco M; Grenga P; Salvatore S; Pelaia P
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):93-8. PubMed ID: 17674017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and functional changes in retinitis pigmentosa: comparing retinal vessel oximetry to full-field electroretinography, electrooculogram and multifocal electroretinography.
    Todorova MG; Türksever C; Schötzau A; Schorderet DF; Valmaggia C
    Acta Ophthalmol; 2016 May; 94(3):e231-41. PubMed ID: 26490228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RP cone-rod degeneration.
    Heckenlively JR
    Trans Am Ophthalmol Soc; 1987; 85():438-70. PubMed ID: 3447340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flicker electroretinogram in retinitis pigmentosa.
    Massof RW; Johnson MA; Sunness JS; Perry C; Finkelstein D
    Doc Ophthalmol; 1986 Mar; 62(3):231-45. PubMed ID: 3486101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foveal cone involvement in retinitis pigmentosa progression assessed through psychophysical impulse response parameters.
    Dagnelie G; Massof RW
    Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):243-55. PubMed ID: 8425831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation phase of cone phototransduction and the flicker electroretinogram in retinitis pigmentosa.
    Alexander KR; Rajagopalan AS; Raghuram A; Fishman GA
    Vision Res; 2006 Sep; 46(17):2773-85. PubMed ID: 16494917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reading performance in patients with retinitis pigmentosa: a study using the MNREAD charts.
    Virgili G; Pierrottet C; Parmeggiani F; Pennino M; Giacomelli G; Steindler P; Menchini U; Orzalesi N;
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3418-24. PubMed ID: 15452044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.